First Trial Data Report: Positive Findings, High Expectations for CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - September 7, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has released a summarized report on data from the tertiary clinical trials for the "Carotid Stenotic Scan (CSS)" device at Thomas Jefferson University (see press release dated June 29th, 2017). His report views initial evaluations as successful, and confirms the device's value and efficiency.Dr....
2017-09-07 8:30 AM EDT
Dr. Phillip Bendick, Preeminent Vascular Sonographer Joins CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - August 22, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Dr. Phillip J. Bendick, PhD, to the company's advisory staff. Dr. Bendick, a renowned medical sonographer and researcher, will assist CVR in the organization of expanded clinical trials for the "Carotid Stenotic Scan (CSS)" device. Dr. Bendick will bring a wealth of knowledge and an extensive network to CVR. Since...
2017-08-22 8:30 AM EDT
Stroke Prevention Makes Quantum Leap into the Future: CVR Inks Deal with Canon Virginia
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2017) - CVR Global Inc., on behalf of CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), has signed a letter of intent with Canon Virginia, Inc. (CVI), Canon U.S.A., Inc.'s domestic manufacturing subsidiary, for the manufacturer of CVR's Carotid Stenotic Scan (CSS). The CSS is a device being developed for early detection of carotid arterial health, a leading indicator of Stroke.CVR's pairing with CVI, after years...
2017-08-08 8:30 AM EDT
CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that Thomas Jefferson University Hospital — Jefferson Clinical Research Institute has issued an initial trial report, summarizing the clinical trial progress of the Carotid Stenotic Scan (CSS) under the supervision of Principal Investigator Dr. David Whellan MD, MHS, FACC, FAHA. Dr. Whellan commented, "The ENTICES (Evaluation of a...
2017-06-29 12:37 PM EDT
CVR Medical Announces Issuance of Shares for Services
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce that CVR Medical has obtained TSX Venture Exchange approval to issue 243,850 common shares of CVR Medical at a deemed price of $0.3375 per share (the "Shares"), as payment to the Lubow Group that was due for their consulting services pursuant to a consulting agreement with an effective date of January 12, 2017. The Shares...
2017-06-02 5:00 PM EDT
CVR Installs Additional CSS Devices at Thomas Jefferson University and Expands Enrollment Base
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce an update of its clinical trials of the "Carotid Stenotic Scan (CSS)," being conducted through the Jefferson Clinical Research Institute at Thomas Jefferson University under the supervision of Dr. David J. Whellan.Tertiary clinical trials have now been underway for four months at multiple site locations across the Thomas Jefferson...
2017-05-25 8:00 AM EDT
CVR Medical Announces Share Issuance for Services
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") had entered into a consulting agreement with Lubow Group ("Lubow"), a Florida Sole Proprietorship, with an effective date of January 12, 2017 ( the "Consulting Agreement"). Pursuant to the Consulting Agreement, after the initial 60 day term of the Consulting Agreement, CVR Medical has the option to pay Lubow the US$60,000 (CDN$82,300) that was due for their...
2017-05-12 5:00 PM EDT
CVR Medical Provides Update on its Thomas Jefferson University Clinical Trials
Vancouver, British Columbia--(Newsfile Corp. - April 25, 2017) - CVR Medical Corp. (TSXV: CVM) ("CVR Medical") announces update on clinical trials of the "Carotid Stenotic Scan (CSS)," currently being conducted through the Jefferson Clinical Research Institute at Thomas Jefferson University under the supervision of Dr. David J. Whellan."Enrollment was initiated in early January," says Dr. Whellan. "The prototype device, which is being operated in standard form, will soon be joined by its...
2017-04-25 8:30 AM EDT
CVR Medical Announces Closing of Second Tranche of Financing
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed the second and final tranche (the "Second Tranche") of its previously announced non-brokered private placement financing (the "Financing").As previously announced, an aggregate of 7,521,768 units ("Units") at a price of $0.48 per Unit were issued in the First Tranche for gross proceeds of $3.6 million. The Company has...
2017-04-24 8:30 AM EDT
CVR Medical Announces Closing of First Tranche of Financing
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement financing (the "Financing").An aggregate of 7,521,768 units ("Units") at a price of $0.48 per Unit were issued in the First Tranche for gross proceeds of $3.6 million. The Company currently expects to close a second and...
2017-04-20 8:30 AM EDT
CVR Medical Announces Amended Financing Price
Vancouver, British Columbia--(Newsfile Corp. - March 29, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") previously announced its intention to complete a private placement financing of units for gross proceeds of up to $5,000,000 (the "Financing"), at a proposed price of $0.45 per unit. After consultation with the TSX Venture Exchange, CVR Medical has amended the proposed purchase price of the Financing to $0.48 per unit. All other aspects of the Financing...
2017-03-29 8:30 AM EDT
CVR Medical Announces Proposed $5M Institutionally Led Financing
Vancouver, British Columbia--(Newsfile Corp. - March 20, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") a leading research and development company aiming to make arterial diagnostic testing significantly more accessible with its "Carotid Stenotic Scan (CSS)" device, is pleased to announce its intention to complete an institutionally led non-brokered private placement financing for gross proceeds of up to $5,000,000 (the "Financing"). The Financing will...
2017-03-20 8:30 AM EDT
CVR Medical Teams with Tech Manufacturer ADCO Circuits
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces partnership with ADCO Circuits, a Michigan-based electronic design and manufacturing company. ADCO will be the exclusive provider of the custom circuit board inside the sensor of CVR's "Carotid Stenotic Scan (CSS)" device.ADCO Circuits is a certified ISO 9002, ISO AS9100, and ISO TS16949 manufacturer of electronic assemblies and full system box...
2017-03-16 8:30 AM EDT
CVR Medical Announces Cancellation of Warrant Acceleration Terms
Vancouver, British Columbia--(Newsfile Corp. - March 13, 2017) - CVR Medical Corp. (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce today that it has cancelled and will not utilize the acceleration provisions in regards to 11,024,612 warrants previously issued (the "Warrants"). If the average closing price of CVR Medical's common shares closed at or above $0.60 for ten consecutive trading days, CVR Medical would have been able to accelerate the term for the...
2017-03-13 8:30 AM EDT
CVR Medical Announces Letter of Intent to Acquire Additional Interest
Vancouver, British Columbia--(Newsfile Corp. - March 9, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has entered into a letter of intent with CVR Global Inc. ("CVR Global") to acquire an additional 10% interest of the "Joint Venture Business" from CVR Global's current 50% interest (the "Transaction"). The Joint Venture Business is held pursuant to, and governed by, the terms of the Joint Venture Agreement between CVR Global and...
2017-03-09 8:30 AM EST
CVR Medical Announces Financing Closing
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed its previously announced non-brokered private placement financing for gross proceeds of $2,500,000 (the "Financing").An aggregate of 7,142,858 units ("Units") were issued at a price of $0.35 per Unit. Net proceeds will be used by the Company for working capital in respect of the Company's joint venture with CVR...
2017-02-23 8:30 AM EST
CVR Medical Announces Amended Financing Terms
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") previously announced its intention to complete a private placement financing for gross proceeds of up to $2,500,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and one-half of one common share purchase warrant at a proposed price of $0.33 per unit, or such other price per unit determined by CVR...
2017-02-13 8:30 AM EST
CVR Medical Appoints Mr. Benjamin Asuncion to the Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Benjamin Asuncion to its Board of Directors. From this position, Mr. Asuncion will serve in capital market advisory and valuation capacities as CVR Medical moves towards market launch.Benjamin Asuncion has over a decade of experience in the capital markets and resources sector. Mr. Asuncion was at Haywood Securities Inc., a privately owned...
2017-02-09 8:30 AM EST
CVR Medical Announces Increase to Previously Announced Financing
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or the "Company") is pleased to announce that, due to strong demand, the Company has increased the size of its previously announced private placement financing to 7.58 million units (the "Units"), at a price of $0.33 per unit, for aggregate gross proceeds to the Company of approximately $2.5 million (the "Financing"). Each unit is comprised of one common...
2017-02-07 3:28 PM EST
CVR Medical Announces Proposed Financing
Vancouver, British Columbia--(Newsfile Corp. - February 6, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that it intends to complete a private placement financing for gross proceeds of up to $1,250,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and one-half of one common share purchase warrant at a price of $0.33 per unit, or such other price per unit determined by CVR Medical management...
2017-02-06 10:38 AM EST